Press Room

News / Mar 04, 2020

Hovione scholarship program supports four students from IST

Hovione renews the scholarship of three students and extended the support to one student

Hovione scholarship program supports four students from IST | Hovione
The students with Hélder Delgado, Sustainability Specialist at Hovione.

Hovione renews the scholarship of three students and extends the support to one student, all from the Instituto Superior Técnico (IST). The ceremony took place on Tuesday, 3rd March. Hovione’s scholarship program – “Hovione Solidária na Educação” – will continue to support Ricardo Dias, Beatriz Colaço and Ana Oliveira (Chemical engineering students) and will extend the support to Mariana Carreira Bento (Biomedical engineering student).

“These scholarships are a way of expressing our gratitude to the universities that produce the most employable graduates and also a way of supporting students with outstanding academic merit who need financial aid”. Hélder Delgado gave an example of a former scholarship recipient from Técnico who is currently working at Hovione and expressed his wish that what has happened before may happen again with these students. “We want to turn this support into useful relationships between our company and students”.

 

Read the entire article on IST's website

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026